Pure Global

Baijie ovarian cancer antigen 125 enzyme immunoassay group - Taiwan Registration 5fae966a14222fbd1245cac7d2009fe3

Access comprehensive regulatory information for Baijie ovarian cancer antigen 125 enzyme immunoassay group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5fae966a14222fbd1245cac7d2009fe3 and manufactured by BIOCHECK, INC.. The authorized representative in Taiwan is GENERAL BIOLOGICALS CORP..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
5fae966a14222fbd1245cac7d2009fe3
Registration Details
Taiwan FDA Registration: 5fae966a14222fbd1245cac7d2009fe3
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Baijie ovarian cancer antigen 125 enzyme immunoassay group
TW: ไฝฐๆฐๅตๅทข็™ŒๆŠ—ๅŽŸ125้…ต็ด ๅ…็–ซๅˆ†ๆž็ต„
Risk Class 2
Cancelled

Registration Details

5fae966a14222fbd1245cac7d2009fe3

DHA00601783309

Company Information

United States

Product Details

It is used for the quantitative analysis of serum turbidity of tumor antigen CA125.

C Immunology and microbiology

C.6010 ่…ซ็˜ค็›ธ้—œๆŠ—ๅŽŸๅ…็–ซ่ฉฆ้ฉ—็ณป็ตฑ

import

Dates and Status

Dec 13, 2006

Dec 13, 2011

May 05, 2014

Cancellation Information

Logged out

่จฑๅฏ่ญ‰ๅทฒ้€พๆœ‰ๆ•ˆๆœŸ